These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30955866)

  • 1. Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
    Guedeney P; Claessen BE; Baber U; Camaj A; Sorrentino S; Aquino M; Blum M; Chandiramani R; Goel R; Elsayed S; Kovacic JC; Sweeny J; Barman N; Moreno P; Dangas GD; Kini A; Sharma S; Mehran R
    Am J Cardiol; 2019 Jun; 123(11):1788-1795. PubMed ID: 30955866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal trends, determinants, and impact of high-intensity statin prescriptions after percutaneous coronary intervention: Results from a large single-center prospective registry.
    Guedeney P; Baber U; Claessen B; Aquino M; Camaj A; Sorrentino S; Vogel B; Farhan S; Faggioni M; Chandrasekhar J; Kalkman DN; Kovacic JC; Sweeny J; Barman N; Moreno P; Vijay P; Shah S; Dangas G; Kini A; Sharma S; Mehran R
    Am Heart J; 2019 Jan; 207():10-18. PubMed ID: 30404046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The residual risk of inflammation and remnant cholesterol in acute coronary syndrome patients on statin treatment undergoing percutaneous coronary intervention.
    Liao J; Qiu M; Su X; Qi Z; Xu Y; Liu H; Xu K; Wang X; Li J; Li Y; Han Y
    Lipids Health Dis; 2024 Jun; 23(1):172. PubMed ID: 38849939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Intensity Versus Non-High-Intensity Statins in Patients Achieving Low-Density Lipoprotein Cholesterol Goal After Percutaneous Coronary Intervention.
    Kim J; Park KT; Jang MJ; Park TK; Lee JM; Yang JH; Song YB; Choi SH; Gwon HC; Lee SH; Hong KP; Hahn JY
    J Am Heart Assoc; 2018 Nov; 7(21):e009517. PubMed ID: 30376751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.
    Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A
    Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients.
    Munkhaugen J; Sverre E; Otterstad JE; Peersen K; Gjertsen E; Perk J; Gullestad L; Moum T; Dammen T; Husebye E
    Eur J Prev Cardiol; 2017 Jun; 24(9):981-989. PubMed ID: 28196429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypocholesterolaemia and mortality in patients with coronary artery disease.
    Ndrepepa G; Holdenrieder S; Cassese S; Xhepa E; Fusaro M; Kastrati A
    Eur J Clin Invest; 2020 Feb; 50(2):e13194. PubMed ID: 31863458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl.
    Piao ZH; Jin L; Kim JH; Ahn Y; Kim YJ; Cho MC; Kim CJ; Kim HS; Liu B; Jeong MH;
    Am J Cardiol; 2017 Jul; 120(2):174-180. PubMed ID: 28532771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry).
    Dasari TW; Cohen DJ; Kleiman NS; Keyes MJ; Yen CH; Hanna EB; Saucedo JF
    Am J Cardiol; 2014 Feb; 113(4):621-5. PubMed ID: 24342762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin initiation following coronary artery bypass grafting: outcome of a hospital discharge protocol.
    Khanderia U; Townsend KA; Eagle K; Prager R
    Chest; 2005 Feb; 127(2):455-63. PubMed ID: 15705982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal Trends of High-Intensity Statin Therapy Among Veterans Treated With Percutaneous Coronary Intervention.
    Bin Abdulhak AA; Vaughan-Sarrzin M; Kaboli P; Horwitz PA; Mosher H; Sigurdsson G; Walker NE; Wallace R; Robinson JG
    J Am Heart Assoc; 2018 Mar; 7(5):. PubMed ID: 29503265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observational Prospective study to esTIMAte the rates of outcomes in patients undergoing PCI with drug-eluting stent implantation who take statins -follow-up (OPTIMA II).
    Karpov Y; Logunova N; Tomilova D; Buza V; Khomitskaya Y
    Curr Med Res Opin; 2017 Feb; 33(2):253-259. PubMed ID: 27779436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical impact of decreased low-density lipoprotein cholesterol level at baseline on the long-term prognosis in patients with acute coronary syndrome.
    Nakahashi T; Tada H; Sakata K; Yakuta Y; Tanaka Y; Nomura A; Gamou T; Terai H; Horita Y; Ikeda M; Namura M; Takamura M; Hayashi K; Yamagishi M; Kawashiri MA
    Heart Vessels; 2018 Jul; 33(7):695-705. PubMed ID: 29288404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Lipoprotein (a) on Long-Term Outcomes in Patients with Coronary Artery Disease Treated with Statin After a First Percutaneous Coronary Intervention.
    Suwa S; Ogita M; Miyauchi K; Sonoda T; Konishi H; Tsuboi S; Wada H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Daida H
    J Atheroscler Thromb; 2017 Nov; 24(11):1125-1131. PubMed ID: 28321012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density lipoprotein cholesterol as a predictor of clinical outcomes in patients achieving low-density lipoprotein cholesterol targets with statins after percutaneous coronary intervention.
    Seo SM; Choo EH; Koh YS; Park MW; Shin DI; Choi YS; Park HJ; Kim DB; Her SH; Lee JM; Park CS; Kim PJ; Moon KW; Chang K; Kim HY; Yoo KD; Jeon DS; Chung WS; Park YG; Seung KB;
    Heart; 2011 Dec; 97(23):1943-50. PubMed ID: 21665885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.
    Natsuaki M; Furukawa Y; Morimoto T; Nakagawa Y; Ono K; Kaburagi S; Inada T; Mitsuoka H; Taniguchi R; Nakano A; Kita T; Sakata R; Kimura T;
    Circ J; 2012; 76(6):1369-79. PubMed ID: 22447012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Trends, Effectiveness, and Safety of Statins on Lipid Goal Attainment in Chinese Percutaneous Coronary Intervention Patients: a Multicenter, Retrospective Cohort Study.
    Chen Y; Li D; Jing J; Yan H; Liu J; Shen Z; James S; Varenhorst C
    Clin Ther; 2017 Sep; 39(9):1827-1839.e1. PubMed ID: 28807393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Low-Dose Statin Versus Low-Dose Statin + Armolipid Plus in High-Intensity Statin-Intolerant Patients With a Previous Coronary Event and Percutaneous Coronary Intervention (ADHERENCE Trial).
    Marazzi G; Campolongo G; Pelliccia F; Quattrino S; Vitale C; Cacciotti L; Massaro R; Volterrani M; Rosano G
    Am J Cardiol; 2017 Sep; 120(6):893-897. PubMed ID: 28781026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of routine in-hospital assessment of low-density lipoprotein levels and standardized orders on statin therapy in patients undergoing percutaneous coronary interventions.
    Ahmad M; Schwalm JD; Velianou JL; Natarajan MK
    J Invasive Cardiol; 2005 Oct; 17(10):518-20. PubMed ID: 16204743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol.
    Lee KH; Jeong MH; Kim HM; Ahn Y; Kim JH; Chae SC; Kim YJ; Hur SH; Seong IW; Hong TJ; Choi DH; Cho MC; Kim CJ; Seung KB; Chung WS; Jang YS; Rha SW; Bae JH; Cho JG; Park SJ;
    J Am Coll Cardiol; 2011 Oct; 58(16):1664-71. PubMed ID: 21982310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.